Fragility Index in Cardiovascular Randomized Controlled Trials

BACKGROUND: Efficacy of an intervention is commonly evaluated using P values, in addition to effect size measures such as absolute risk reduction, relative risk reduction, and numbers needed to treat. However, these measures are not always intuitive to clinicians. The fragility index (FI) is a more...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circ Cardiovasc Qual Outcomes
Hlavní autoři: Khan, Muhammad Shahzeb, Ochani, Rohan Kumar, Shaikh, Asim, Usman, Muhammad Shariq, Yamani, Naser, Khan, Safi U., Murad, M. Hassan, Mandrola, John, Doukky, Rami, Krasuski, Richard A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7962007/
https://ncbi.nlm.nih.gov/pubmed/31822121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.119.005755
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky